Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KURA
KURA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KURA News
Kura Oncology Reports Positive Phase 1 Trial Results for Darlifarnib
4d ago
NASDAQ.COM
Kura Oncology Reports Promising Results for Darlifarnib in Cancer Treatment
4d ago
Newsfilter
Kura Oncology Reports Strong Q1 2026 Earnings with $5.8M Revenue
May 13 2026
seekingalpha
Kura Oncology Reports Q1 2026 Earnings with Mixed Results
May 13 2026
Yahoo Finance
Kura Oncology Q1 Earnings Miss Expectations
May 12 2026
seekingalpha
Kura Oncology Presents AML Clinical Trial Data with Promising Results
May 12 2026
Newsfilter
Kura Oncology Set to Announce Q1 Earnings Results
May 12 2026
seekingalpha
Kura Oncology Grants Stock Options to New Employees
May 04 2026
Newsfilter
Health Care Stocks Rise 1.4% on NYSE
Apr 17 2026
Yahoo Finance
Kura Oncology Reports Promising Kidney Cancer Trial Results
Apr 17 2026
stocktwits
Kura Oncology Reports Positive Data for Kidney Cancer Drug
Apr 17 2026
seekingalpha
Kura Oncology Reveals New Data on Darlifarnib and Cabozantinib Combination Therapy Potential
Apr 17 2026
Newsfilter
Kura Oncology Presents Darlifarnib Clinical Data at IKCS Europe 2026
Apr 09 2026
Newsfilter
Kura Oncology Grants Stock Options to New Employees
Apr 03 2026
Newsfilter
KURA ONCOLOGY INC: MIZUHO LOWERS TARGET PRICE FROM $30 TO $25
Mar 25 2026
moomoo
Kura Oncology Grants Stock Options to New Employees
Mar 06 2026
Newsfilter
Show More News
